{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:18:19Z","timestamp":1793841499162,"version":"4.6.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-92630-4","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T18:42:06Z","timestamp":1742582526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["A diagnostic model for polycystic ovary syndrome based on machine learning"],"prefix":"10.1038","volume":"15","author":[{"given":"Cheng","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenchao","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5157-4053","authenticated-orcid":false,"given":"Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"issue":"1","key":"92630_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0038-1668085","volume":"36","author":"ACH Neven","year":"2018","unstructured":"Neven, A. C. H., Laven, J., Teede, H. J. & Boyle, J. A. A summary on polycystic ovary syndrome: diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines. Semin. Reprod. Med. 36(1), 5\u201312 (2018).","journal-title":"Semin. Reprod. Med."},{"issue":"9","key":"92630_CR2","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.3390\/jcm9092700","volume":"9","author":"D Mayrhofer","year":"2020","unstructured":"Mayrhofer, D. et al. The Prevalence and impact of polycystic ovary syndrome in recurrent miscarriage: A retrospective cohort study and meta-analysis. J. Clin. Med. 9(9), 2700 (2020).","journal-title":"J. Clin. Med."},{"issue":"7","key":"92630_CR3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tcm.2019.08.010","volume":"30","author":"O Osibogun","year":"2020","unstructured":"Osibogun, O., Ogunmoroti, O. & Michos, E. D. Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention. Trends Cardiovasc. Med. 30(7), 399\u2013404 (2020).","journal-title":"Trends Cardiovasc. Med."},{"issue":"9","key":"92630_CR4","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1017\/S0033291718002076","volume":"49","author":"AL Damone","year":"2019","unstructured":"Damone, A. L. et al. Depression, anxiety and perceived stress in women with and without PCOS: A community-based study. Psychol. Med. 49(9), 1510\u20131520 (2019).","journal-title":"Psychol. Med."},{"issue":"2","key":"92630_CR5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/09513590.2019.1650340","volume":"36","author":"W Tian","year":"2020","unstructured":"Tian, W. et al. High level of visfatin and the activation of Akt and ERK1\/2 signaling pathways are associated with endometrium malignant transformation in polycystic ovary syndrome. Gynecol Endocrinol. 36(2), 156\u2013161 (2020).","journal-title":"Gynecol Endocrinol."},{"key":"92630_CR6","doi-asserted-by":"crossref","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 81(1), 19\u201325 (2004).","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"issue":"2","key":"92630_CR7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ejendo\/lvad096","volume":"189","author":"HJ Teede","year":"2023","unstructured":"Teede, H. J. et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur. J. Endocrinol. 189(2), 43\u201364 (2023).","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"92630_CR8","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1210\/clinem\/dgac039","volume":"107","author":"MI Cedars","year":"2022","unstructured":"Cedars, M. I. Evaluation of female fertility-AMH and ovarian reserve testing. J. Clin. Endocrinol. Metab. 107(6), 1510\u20131519 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"92630_CR9","first-page":"567","volume":"45","author":"Y Li","year":"2010","unstructured":"Li, Y., Wei, L. N., Xiong, Y. L. & Liang, X. Y. Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-M\u00fcllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome. Zhonghua Fu Chan Ke Za Zhi. 45(8), 567\u2013570 (2010).","journal-title":"Zhonghua Fu Chan Ke Za Zhi."},{"key":"92630_CR10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.lfs.2019.04.046","volume":"228","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sci. 228, 167\u2013175 (2019).","journal-title":"Life Sci."},{"issue":"8","key":"92630_CR11","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/humrep\/dep113","volume":"24","author":"O Valkenburg","year":"2009","unstructured":"Valkenburg, O. et al. Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome. Hum. Reprod. 24(8), 2014\u20132022 (2009).","journal-title":"Hum. Reprod."},{"issue":"6","key":"92630_CR12","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s43032-019-00137-x","volume":"27","author":"A Arroyo","year":"2020","unstructured":"Arroyo, A., Kim, B. & Yeh, J. Luteinizing hormone action in human oocyte maturation and quality: Signaling pathways, regulation, and clinical impact. Reprod. Sci. 27(6), 1223\u20131252 (2020).","journal-title":"Reprod. Sci."},{"issue":"2","key":"92630_CR13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/genes11020196","volume":"11","author":"P Jiao","year":"2020","unstructured":"Jiao, P. et al. PRL\/microRNA-183\/IRS1 pathway regulates milk fat metabolism in cow mammary epithelial cells. Genes (Basel). 11(2), 196 (2020).","journal-title":"Genes (Basel)."},{"key":"92630_CR14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3389\/fendo.2020.00263","volume":"11","author":"H Yang","year":"2020","unstructured":"Yang, H. et al. The association between prolactin and metabolic parameters in PCOS women: A retrospective analysis. Front. Endocrinol. (Lausanne). 11, 263 (2020).","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"10","key":"92630_CR15","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3390\/cells8101123","volume":"8","author":"ZR Tang","year":"2019","unstructured":"Tang, Z. R., Zhang, R., Lian, Z. X., Deng, S. L. & Yu, K. Estrogen-receptor expression and function in female reproductive disease. Cells. 8(10), 1123 (2019).","journal-title":"Cells."},{"issue":"1","key":"92630_CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/17460441.2019.1549033","volume":"14","author":"VG Maltarollo","year":"2019","unstructured":"Maltarollo, V. G., Kronenberger, T., Espinoza, G. Z., Oliveira, P. R. & Honorio, K. M. Advances with support vector machines for novel drug discovery. Expert Opin. Drug Discov. 14(1), 23\u201333 (2019).","journal-title":"Expert Opin. Drug Discov."},{"issue":"6","key":"92630_CR17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1210\/endrev\/bnab012","volume":"42","author":"N di Clemente","year":"2021","unstructured":"di Clemente, N., Racine, C., Pierre, A. & Taieb, J. Anti-M\u00fcllerian hormone in female reproduction. Endocr. Rev. 42(6), 753\u2013782 (2021).","journal-title":"Endocr. Rev."},{"issue":"3","key":"92630_CR18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly, D. et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum. Reprod. Update. 20(3), 370\u2013385 (2014).","journal-title":"Hum. Reprod. Update."},{"issue":"1","key":"92630_CR19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10815-019-01622-7","volume":"37","author":"J Bedenk","year":"2020","unstructured":"Bedenk, J., Vrta\u010dnik-Bokal, E. & Virant-Klun, I. The role of anti-M\u00fcllerian hormone (AMH) in ovarian disease and infertility. J. Assist. Reprod. Genet. 37(1), 89\u2013100 (2020).","journal-title":"J. Assist. Reprod. Genet."},{"issue":"6","key":"92630_CR20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","volume":"9","author":"AH Balen","year":"2003","unstructured":"Balen, A. H., Laven, J. S., Tan, S. L. & Dewailly, D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum. Reprod. Update. 9(6), 505\u2013514 (2003).","journal-title":"Hum. Reprod. Update."},{"issue":"4","key":"92630_CR21","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1017\/S0033291719000424","volume":"50","author":"CE Cesta","year":"2020","unstructured":"Cesta, C. E. et al. Maternal polycystic ovary syndrome and risk of neuropsychiatric disorders in offspring: prenatal androgen exposure or genetic confounding?. Psychol. Med. 50(4), 616\u2013624 (2020).","journal-title":"Psychol. Med."},{"issue":"1","key":"92630_CR22","first-page":"59.e51","volume":"211","author":"R Tal","year":"2014","unstructured":"Tal, R. et al. Characterization of women with elevated antim\u00fcllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes. Am. J. Obstet. Gynecol. 211(1), 59.e51\u201358 (2014).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"92630_CR23","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/s41467-021-21308-y","volume":"12","author":"C Bourgneuf","year":"2021","unstructured":"Bourgneuf, C. et al. The Goto-Kakizaki rat is a spontaneous prototypical rodent model of polycystic ovary syndrome. Nat. Commun. 12(1), 1064 (2021).","journal-title":"Nat. Commun."},{"issue":"2","key":"92630_CR24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s13224-013-0482-3","volume":"64","author":"M Dayal","year":"2014","unstructured":"Dayal, M., Sagar, S., Chaurasia, A. & Singh, U. Anti-mullerian hormone: A new marker of ovarian function. J. Obstet. Gynaecol. India. 64(2), 130\u2013133 (2014).","journal-title":"J. Obstet. Gynaecol. India."},{"issue":"3","key":"92630_CR25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/humupd\/dmac004","volume":"28","author":"RA Anderson","year":"2022","unstructured":"Anderson, R. A. et al. Anti-M\u00fcllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review. Hum. Reprod. Update. 28(3), 417\u2013434 (2022).","journal-title":"Hum. Reprod. Update."},{"issue":"5","key":"92630_CR26","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/cen.14592","volume":"95","author":"RM Islam","year":"2021","unstructured":"Islam, R. M., Bell, R. J., Skiba, M. A. & Davis, S. R. Testosterone and androstenedione are positively associated with anti-M\u00fcllerian hormone in premenopausal women. Clin. Endocrinol. (Oxf). 95(5), 752\u2013759 (2021).","journal-title":"Clin. Endocrinol. (Oxf)."},{"issue":"4","key":"92630_CR27","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/humrep\/dey017","volume":"33","author":"M Peign\u00e9","year":"2018","unstructured":"Peign\u00e9, M. et al. The numbers of 2\u20135 and 6\u20139 mm ovarian follicles are inversely correlated in both normal women and in polycystic ovary syndrome patients: what is the missing link?. Hum. Reprod. 33(4), 706\u2013714 (2018).","journal-title":"Hum. Reprod."},{"issue":"12","key":"92630_CR28","first-page":"2467","volume":"34","author":"N Dilaver","year":"2019","unstructured":"Dilaver, N. et al. The regulation and signalling of anti-M\u00fcllerian hormone in human granulosa cells: Relevance to polycystic ovary syndrome. Hum. Reprod. 34(12), 2467\u20132479 (2019).","journal-title":"Hum. Reprod."},{"issue":"7","key":"92630_CR29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/09513590.2018.1559807","volume":"35","author":"H Sova","year":"2019","unstructured":"Sova, H. et al. Hormone profiling, including anti-M\u00fcllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes. Gynecol. Endocrinol. 35(7), 595\u2013600 (2019).","journal-title":"Gynecol. Endocrinol."},{"issue":"3","key":"92630_CR30","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/humrep\/des460","volume":"28","author":"A Pierre","year":"2013","unstructured":"Pierre, A. et al. Loss of LH-induced down-regulation of anti-M\u00fcllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome. Hum. Reprod 28(3), 762\u2013769 (2013).","journal-title":"Hum. Reprod"},{"issue":"11","key":"92630_CR31","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2017-00308","volume":"102","author":"A Pierre","year":"2017","unstructured":"Pierre, A. et al. Dysregulation of the Anti-M\u00fcllerian hormone system by steroids in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 102(11), 3970\u20133978 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"92630_CR32","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1007\/s43032-022-00985-0","volume":"29","author":"J Ge","year":"2022","unstructured":"Ge, J. et al. Steroid hormone profiling in hyperandrogenism and non-hyperandrogenism women with polycystic ovary syndrome. Reprod. Sci. 29(12), 3449\u20133458 (2022).","journal-title":"Reprod. Sci."},{"issue":"9","key":"92630_CR33","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1210\/jc.2009-0837","volume":"94","author":"DA Vassiliadi","year":"2009","unstructured":"Vassiliadi, D. A. et al. Increased 5 alpha-reductase activity and adrenocortical drive in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 94(9), 3558\u20133566 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"92630_CR34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jsbmb.2014.06.003","volume":"145","author":"MO Goodarzi","year":"2015","unstructured":"Goodarzi, M. O., Carmina, E. & Azziz, R. DHEA, DHEAS and PCOS. J. Steroid Biochem. Mol. Biol. 145, 213\u2013225 (2015).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"92630_CR35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/jcm10010119","volume":"10","author":"G Grassi","year":"2020","unstructured":"Grassi, G. et al. Hyperandrogenism by liquid chromatography tandem mass spectrometry in PCOS: Focus on testosterone and androstenedione. J. Clin. Med. 10(1), 119 (2020).","journal-title":"J. Clin. Med."},{"issue":"8","key":"92630_CR36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.eprac.2023.05.007","volume":"29","author":"W Yi","year":"2023","unstructured":"Yi, W. et al. A model combining testosterone, androstenedione and free testosterone index improved the diagnostic efficiency of polycystic ovary syndrome. Endocr. Pract. 29(8), 629\u2013636 (2023).","journal-title":"Endocr. Pract."},{"issue":"1","key":"92630_CR37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12958-018-0438-7","volume":"16","author":"W Yang","year":"2018","unstructured":"Yang, W. et al. Body mass index and basal androstenedione are independent risk factors for miscarriage in polycystic ovary syndrome. Reprod. Biol. Endocrinol. 16(1), 119 (2018).","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"15","key":"92630_CR38","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1016\/j.biortech.2008.01.039","volume":"99","author":"A Malaviya","year":"2008","unstructured":"Malaviya, A. & Gomes, J. Androstenedione production by biotransformation of phytosterols. Bioresour. Technol. 99(15), 6725\u20136737 (2008).","journal-title":"Bioresour. Technol."},{"issue":"3","key":"92630_CR39","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1530\/EJE-09-0741","volume":"162","author":"JH Barth","year":"2010","unstructured":"Barth, J. H., Field, H. P., Yasmin, E. & Balen, A. H. Defining hyperandrogenism in polycystic ovary syndrome: Measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots. Eur. J. Endocrinol. 162(3), 611\u2013615 (2010).","journal-title":"Eur. J. Endocrinol."},{"issue":"Pt A","key":"92630_CR40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cbi.2016.06.008","volume":"259","author":"AE S\u00f8rensen","year":"2016","unstructured":"S\u00f8rensen, A. E., Udesen, P. B., Wissing, M. L., Englund, A. L. M. & Dalgaard, L. T. MicroRNAs related to androgen metabolism and polycystic ovary syndrome. Chem. Biol. Interact. 259(Pt A), 8\u201316 (2016).","journal-title":"Chem. Biol. Interact."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92630-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92630-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92630-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T18:42:47Z","timestamp":1742582567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92630-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92630"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92630-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The study was approved by the Ethics Committee of the First Affiliated Hospital of Zhejiang Chinese Medical University (Ethics Approval No. 2023\u2013KLS\u2013244\u201301). The biological samples used in this study were obtained from the secondary use of samples previously kept by the participants, thus, this study has applied to the Ethics Committee for a waiver of written informed consent from the patients in this study. All methods were in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"9821"}}